WebNews
Please enter a web search for web results.
NewsWeb
Sam Neill Announces Cancer Free Status Following CAR T-Cell Therapy
3+ hour, 57+ min ago (377+ words) Renowned Jurassic Park actor Sam Neill has confirmed he is currently cancer-free after receiving a pioneering medical treatment. The 78-year-old actor shared the update while advocating for wider access to specialized therapies for blood cancer patients. As reported by The…...
Using Flow Cytometry to Assess Anti-Drug Antibodies Against CAR T Cells
14+ hour, 37+ min ago (343+ words) News and views from the American Association of Immunologists Researchers have developed a flow cytometry assay to detect anti-drug antibodies (ADAs) binding to CAR T cells in a dose-dependent manner. While CAR T Cell therapy has been highly effective as…...
Harvard couple wins $3 M 'Oscar of Science' for first gene therapy to reverse childhood blindness
19+ hour, 36+ min ago (371+ words) Molecular biologist Jean Bennett, 71, and her husband, ophthalmic surgeon Albert Maguire, 66, both emeritus professors at the University of Pennsylvania, share the US$3 million prize with physician-scientist Katherine High, 74, CEO of Rhy Gaze, a gene therapy company based in Switzerland and…...
From bench to bedside: Christine Kinnon, curing rare diseases through gene therapy
18+ hour, 34+ min ago (505+ words) Christine Kinnon's work helped turn gene therapy from an experimental idea into treatments that have cured children born with immunodeficiency diseases. The first in her family to go to university, Professor Christine Kinnon first caught the "research bug' while studying…...
Intellia Therapeutics CRISPR Trial Win Puts One-Time HAE Drug On FDA Track
1+ day, 10+ hour ago (523+ words) Cambridge, Massachusetts, April 27, 2026, 15: 04 EDT Timing comes into play here: Intellia has shifted the program from simply reporting clinical data to lining up for regulatory review. A biologics license application'BLA'is what companies file to seek U. S. approval for a biologic drug. "In…...
Profluent Announces Strategic Partnership with Lilly to Develop AI-Designed Recombinases for Genetic Medicine
13+ hour, 44+ min ago (393+ words) Bio Space Profluent Announces Strategic Partnership with Lilly to Develop AI-Designed Recombinases for Genetic Medicine - Collaboration combines Profluent's frontier AI platform with Lilly's leading capabilities in genetic medicines - AI-designed recombinases aim to unlock kilobase-scale DNA editing capabilities across multiple diseases…...
Precision Bio Sciences Announces Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 2026 Annual Meeting
19+ hour, 3+ min ago (185+ words) Details of the presentation: Abstract title: PBGENE-DMD gene editing drives safe, efficacious, and durable functional improvement in a humanized Duchenne muscular dystrophy mouse model Session: Emerging molecular therapeutic strategies for muscular dystrophies Presenter: Adam Michler Ph. D. , DMD Research Lead Presentation…...
Sana Biotechnology Announces Oral Presentation Highlighting Preclinical Data from in vivo CAR T SG293 at the American Society of Gene & Cell Therapy (ASGCT) 2026 Annual Meeting
1+ day, 9+ hour ago (27+ words) Chart Mill...
Intellia announces CRISPR breakthrough and filing
9+ hour, 52+ min ago (119+ words) CRISPR gene editing specialist Intellia Therapeutics (Nasdaq: NTLA) has announced positive topline results from the global Phase III HAELO clinical trial of lonvo-z in hereditary angioedema (HAE). This article is accessible to registered users, to continue reading please register for…...
Lilly strikes second partnership this year for recombinase-based gene editing
19+ hour, 4+ min ago (62+ words) Endpoints News Lil'ly strikes sec'ond part'ner'ship this year for re'com'bi'nase-based gene edit'ing Decades be'fore CRISPR gene edit'ing was in'vent'ed, sci'en'tists tried to ma'nip'u'late genes with en'zymes called re'com'bi'nas'es. The pro'teins were pre'cise but proved tricky to use " Think we're worth…...